Medications

Are generics as good as brand-name drugs?

(HealthDay)—Generics make up 80 percent of drug prescriptions filled in the United States and are a big cost savings for consumers.

Cardiology

Outcomes-based pricing doesn't cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.

page 13 from 23